VERV: Verve Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 270.83
Enterprise Value ($M) 98.27
Book Value ($M) 493.40
Book Value / Share 5.56
Price / Book 0.55
NCAV ($M) 388.76
NCAV / Share 4.38
Price / NCAV 0.70

Profitability (mra)
Return on Invested Capital (ROIC) -0.35
Return on Assets (ROA) -0.27
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio 12.65
Current Ratio 12.65

Balance Sheet (mrq) ($M)
Current Assets 542.75
Assets 647.39
Liabilities 153.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 32.33
Operating Income -228.66
Net Income -198.71

Cash Flow Statement (mra) ($M)
Cash From Operations -157.69
Cash from Investing 74.88
Cash from Financing 49.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-05 13G State Street Corp 3.80 -23.92
01-31 13G/A Millennium Management Llc 4.60 -26.95
01-10 13G/A ARK Investment Management LLC 0.00 -100.00
11-18 13G Biotechnology Value Fund L P 8.20
11-12 13G/A Vanguard Group Inc 4.73 0.00
11-08 13G/A BlackRock, Inc. 8.60 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 358,976 2,165,215 16.58
2025-04-10 283,735 1,763,076 16.09
2025-04-09 521,958 3,460,345 15.08
2025-04-08 534,971 2,155,541 24.82
2025-04-07 598,400 3,048,865 19.63

(click for more detail)

Similar Companies
TYRA – Tyra Biosciences, Inc. UBX – Unity Biotechnology, Inc.
UTHR – United Therapeutics Corporation VIGL – Vigil Neuroscience, Inc.
VIR – Vir Biotechnology, Inc.


Financial data and stock pages provided by
Fintel.io